BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29525530)

  • 1. Sulforaphane epigenetically demethylates the CpG sites of the miR-9-3 promoter and reactivates miR-9-3 expression in human lung cancer A549 cells.
    Gao L; Cheng D; Yang J; Wu R; Li W; Kong AN
    J Nutr Biochem; 2018 Jun; 56():109-115. PubMed ID: 29525530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation.
    Zhang C; Su ZY; Khor TO; Shu L; Kong AN
    Biochem Pharmacol; 2013 May; 85(9):1398-404. PubMed ID: 23416117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
    Li QQ; Xie YK; Wu Y; Li LL; Liu Y; Miao XB; Liu QZ; Yao KT; Xiao GH
    Oncotarget; 2017 Feb; 8(7):12067-12080. PubMed ID: 28076844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
    Meeran SM; Patel SN; Tollefsbol TO
    PLoS One; 2010 Jul; 5(7):e11457. PubMed ID: 20625516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
    Abbas A; Hall JA; Patterson WL; Ho E; Hsu A; Al-Mulla F; Georgel PT
    Biochem Cell Biol; 2016 Feb; 94(1):71-81. PubMed ID: 26458818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation.
    Martin SL; Kala R; Tollefsbol TO
    Curr Cancer Drug Targets; 2018; 18(1):97-106. PubMed ID: 28176652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
    Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
    Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
    Shiba-Ishii A; Noguchi M
    Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer.
    Khor TO; Fuentes F; Shu L; Paredes-Gonzalez X; Yang AY; Liu Y; Smiraglia DJ; Yegnasubramanian S; Nelson WG; Kong AN
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1186-97. PubMed ID: 25266896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1).
    Gu Y; Zhang Z; Yin J; Ye J; Song Y; Liu H; Xiong Y; Lu M; Zheng G; He Z
    J Exp Clin Cancer Res; 2017 Aug; 36(1):114. PubMed ID: 28859669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells.
    Shu L; Khor TO; Lee JH; Boyanapalli SS; Huang Y; Wu TY; Saw CL; Cheung KL; Kong AN
    AAPS J; 2011 Dec; 13(4):606-14. PubMed ID: 21938566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells.
    Wong CP; Hsu A; Buchanan A; Palomera-Sanchez Z; Beaver LM; Houseman EA; Williams DE; Dashwood RH; Ho E
    PLoS One; 2014; 9(1):e86787. PubMed ID: 24466240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane.
    Su ZY; Zhang C; Lee JH; Shu L; Wu TY; Khor TO; Conney AH; Lu YP; Kong AN
    Cancer Prev Res (Phila); 2014 Mar; 7(3):319-29. PubMed ID: 24441674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
    Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
    PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma.
    Ramnath N; Nadal E; Jeon CK; Sandoval J; Colacino J; Rozek LS; Christensen PJ; Esteller M; Beer DG; Kim SH
    J Thorac Oncol; 2014 Apr; 9(4):473-82. PubMed ID: 24736069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-19 targeting of GSK3β mediates sulforaphane suppression of lung cancer stem cells.
    Zhu J; Wang S; Chen Y; Li X; Jiang Y; Yang X; Li Y; Wang X; Meng Y; Zhu M; Ma X; Huang C; Wu R; Xie C; Geng S; Wu J; Zhong C; Han H
    J Nutr Biochem; 2017 Jun; 44():80-91. PubMed ID: 28431267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.
    Kang N; Choi SY; Kim YK; Yoo IeR; Han DH; Lee DS; Kim YS; Hong SH; Kang JH; Lee KY; Park JK; Sung SW; Park MS; Yim HW; Kim SJ; Park JY
    Lung Cancer; 2015 Aug; 89(2):99-103. PubMed ID: 26101014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
    Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
    Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.